How to Evaluate the Drug Response in Patient-Derived Organoids Using True 3D HCA

Join this expert webinar to find out how imaging and true 3D high-content analysis can benefit drug studies based on patient-derived organoids

16 Jul 2019

Georgina Wynne Hughes

Editorial Assistant

Patient-derived organoids are a useful tool for drug discovery because they mimic human physiology since they are derived from patient cells and have a 3D structure. In this upcoming SelectScience webinar, learn how to apply patient-derived organoids for drug discovery research using imaging and how true 3D analysis contributes to the study.

In this webinar, Olympus imaging expert Brendan Brinkman will discuss:

A drug study based on patient-derived organoids that benefited from using true 3D high-content analysis (HCA)
How truly three-dimensional analysis can improve quantitative results over sub-sampling data sets
How the NoviSight™ HCA software interface links all your confocal 3D data from a microplate experiment in a powerful, visual, analytical interface — including 3D rendering, object segment gallery, heat map, and data mining scatterplot

The live webinar takes place on Tuesday, July 30, 2019, at: